Schedule 13G ownership disclosure

GRI BIO INC

Common stock, par value $0.0001 per share · CUSIP: 3622AW403

Event date: 2025-12-30

Filing-level shares
0.00
Percent of class
0%
  • Lincoln Alternative Strategies LLC

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-26-005944
Form type
SCHEDULE 13G/A
Filer
GRI Bio, Inc.
CIK
CIK 1824293
Filed
Feb 10, 2026
Reporting period
Dec 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub